IP Library › Assignment 019922/0573
Patent Assignment
Reel/Frame 019922/0573

Assignment of Assignor's Interest

Recorded: 2007-10-04 Pages: 4
Assignors
ANDERSON, MARK B.
Executed: 2007-08-23
WILLARDSEN, ADAM
Executed: 2007-08-21
Assignee
MYRIAD GENETICS, INC.
320 WAKARA WAY, SALT LAKE CITY, UTAH, 84108
Covered Property (1)
Method of Treating Brain Cancer
Patent: 8,258,145 →
Application: 11/773,285 →
Publication: US 2008/0051398
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 4, 2007
From: CAI, SUI-XIONG; SIRISOMA, NILANTHA SUDATH
To: CYTOVIA, INC.
Reel/Frame 019922/0630 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023136/0158 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024852/0481 →
Security Agreement Feb 19, 2014
From: IMMUNE PHARMACEUTICALS INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
To: MIDCAP FUNDING III, LLC
Reel/Frame 032277/0353 →
Release of Security Interest Aug 5, 2015
From: MIDCAP FINANCIAL TRUST
To: IMMUNE PHARMACEUTICALS, INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
Reel/Frame 036255/0778 →
Security Interest Oct 9, 2018
From: IMMUNE PHARMACEUTICALS INC.
To: DISCOVER GROWTH FUND, LLC
Reel/Frame 047107/0116 →